Gamma-oryzanol reduces renal inflammation and oxidative stress by modulating AGEs/RAGE axis in animals submitted to high sugar-fat diet.


Journal

Jornal brasileiro de nefrologia
ISSN: 2175-8239
Titre abrégé: J Bras Nefrol
Pays: Brazil
ID NLM: 9426946

Informations de publication

Date de publication:
Historique:
received: 05 01 2021
accepted: 18 04 2021
pubmed: 27 6 2021
medline: 17 12 2021
entrez: 26 6 2021
Statut: ppublish

Résumé

The receptor for AGEs (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface receptors expressed in many organs, among them, the kidneys. When activated, RAGE leads to a sequence of signaling that results in inflammation and oxidative stress, both involved in kidney disease pathogenesis. Gamma-oryzanol (γOz) comprises a mixture of ferulic acid (FA) esters and phytosterols (sterols and triterpene alcohols) mainly found in rice, with antioxidant and anti-inflammatory activities. To evaluate the effect of γOz to reduce renal inflammation and oxidative stress by modulating AGEs/RAGE axis in animals submitted to a high sugar-fat diet. Male Wistar rats (±187g) were randomly divided into two experimental groups: control (n = 7 animals) and high sugar-fat diet (HSF, n = 14 animals) for 20 weeks. After this period, when the presence of renal disease risk factors was detected in the HSF group (insulin resistance, dyslipidemia, increased systolic blood pressure and obesity), the HSF animals were divided to begin the treatment with γOz or continue receiving only HSF for 10 more weeks. No effect of γOz on obesity and metabolic parameters was observed. However, kidney inflammation and oxidative stress decreased as soon as RAGE levels were reduced in HSF + γOz. It is possible to conclude that the gamma- oryzanol was effective in reducing inflammation and oxidative stress in the kidney by modulating the AGEs/RAGE axis.

Identifiants

pubmed: 34174064
pii: S0101-28002021005051301
doi: 10.1590/2175-8239-JBN-2021-0002
pmc: PMC8940121
pii:
doi:

Substances chimiques

Phenylpropionates 0
Sugars 0
gamma-oryzanol SST9XCL51M

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

460-469

Références

Transl Res. 2017 May;183:14-25
pubmed: 28025032
Nephrol Dial Transplant. 1999 Aug;14(8):1968-75
pubmed: 10462279
Anal Biochem. 2014 Aug 1;458:69-71
pubmed: 24814294
PLoS One. 2014 Jun 12;9(6):e98895
pubmed: 24921930
Int J Mol Sci. 2016 Aug 09;17(8):
pubmed: 27517904
Int J Mol Sci. 2019 Jul 29;20(15):
pubmed: 31362427
J Immunol Res. 2018 Sep 6;2018:2180373
pubmed: 30271792
J Altern Complement Med. 2019 Mar;25(3):353-358
pubmed: 30265563
Orv Hetil. 2010 May 23;151(21):864-9
pubmed: 20462846
Oxid Med Cell Longev. 2018 Mar 14;2018:2987249
pubmed: 29725495
J Bras Nefrol. 2017 Mar;39(1):65-69
pubmed: 28355395
Kidney Int Suppl. 2009 Dec;(114):S3-11
pubmed: 19946325
Nat Rev Nephrol. 2010 Jun;6(6):352-60
pubmed: 20421886
Nutrients. 2017 Nov 29;9(12):
pubmed: 29186059
Nutr Metab (Lond). 2018 Oct 10;15:72
pubmed: 30337945
Int J Vitam Nutr Res. 2010 Jan;80(1):45-53
pubmed: 20533244
Oxid Med Cell Longev. 2018 Sep 9;2018:1278392
pubmed: 30271526
Genomics Inform. 2013 Dec;11(4):224-9
pubmed: 24465234
Bioorg Chem. 2020 Jan;94:103478
pubmed: 31806157
Adv Exp Med Biol. 2014;824:191-208
pubmed: 25039001
Cell Metab. 2018 Sep 4;28(3):337-352
pubmed: 30184484
PLoS One. 2015 Feb 03;10(2):e0118135
pubmed: 25646799
Redox Biol. 2019 May;23:101083
pubmed: 30598328
Br J Nutr. 2013 Nov;110(10):1803-9
pubmed: 23632237
Eur J Clin Invest. 2010 Aug;40(8):742-55
pubmed: 20649640
Curr Opin Nephrol Hypertens. 2015 Jan;24(1):74-80
pubmed: 25402870
Antioxidants (Basel). 2019 Sep 02;8(9):
pubmed: 31480719
Eur J Clin Chem Clin Biochem. 1997 Sep;35(9):669-77
pubmed: 9352229
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Indian J Med Res. 2014 Jun;139(6):857-63
pubmed: 25109720
Semin Dial. 2009 Jul-Aug;22(4):400-4
pubmed: 19708990
Cell Physiol Biochem. 2018;48(2):705-717
pubmed: 30025404
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825

Auteurs

Fabiane Valentini Francisqueti-Ferron (FV)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Artur Junio Togneri Ferron (AJT)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Alessandra Altomare (A)

Università degli Studi di Milano, Department of Pharmaceutical Sciences (DISFARM), Milan, Italy.

Jéssica Leite Garcia (JL)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Fernando Moreto (F)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Ana Lúcia A Ferreira (ALA)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Igor Otávio Minatel (IO)

Universidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatu, SP, Brasil.

Giancarlo Aldini (G)

Università degli Studi di Milano, Department of Pharmaceutical Sciences (DISFARM), Milan, Italy.

Camila Renata Corrêa (CR)

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, SP, Brasil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH